Cargando…
Validation of a Molecular Diagnostic Test for Circulating Tumor DNA by Next-Gen Sequencing
A modified version of the PGDx elio(TM) Plasma Resolve assay was validated as a laboratory-developed test (LDT) for clinical use in the Molecular Diagnostics Laboratory at Fox Chase Cancer Center. The test detects single nucleotide variants (SNVs) and small insertions and deletions (indels) in 33 ta...
Autores principales: | Fernandez, Sandra V., Tan, Yin Fei, Rao, Shilpa, Fittipaldi, Patricia, Sheriff, Fathima, Borghaei, Hossein, Dotan, Efrat, Winn, Jennifer S., Edelman, Martin J., Treat, Joseph, Judd, Julia, Alpaugh, R. Katherine, Wang, Y. Lynn, Yu, Jian Q., Wasik, Mariusz, Baldwin, Don A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10648112/ https://www.ncbi.nlm.nih.gov/pubmed/37958763 http://dx.doi.org/10.3390/ijms242115779 |
Ejemplares similares
-
Circulating tumor cell and cell-free RNA capture and expression analysis identify platelet-associated genes in metastatic lung cancer
por: Beck, Tim N., et al.
Publicado: (2019) -
The Next Gen Leader
por: McMillan, Robert
Publicado: (2014) -
Flipping NextGen: using biological systems to characterize NextGen sequencing technologies
por: Glasscock, Jarret, et al.
Publicado: (2009) -
The PHEDEx next-gen website
por: Wildish, Anthony
Publicado: (2012) -
5 Musts for Next-Gen Leaders
por: Mukherjee, Amit
Publicado: (2020)